https://www.globenewswire.com/news-release/2017/02/21/925779/0/en/Momenta-Pharmaceuticals-Reports-Fourth-Quarter-and-Year-End-2016-Financial-Results.html
Momenta Pharmaceuticals Reports Fourth Quarter and Year End
CAMBRIDGE, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth...
momenta pharmaceuticalsfourth quarterreportsyearend
https://www.fool.com/investing/2018/01/05/why-momenta-pharmaceuticals-rallied-156-today.aspx
Why Momenta Pharmaceuticals Rallied 15.6% Today | The Motley Fool
Jan 5, 2018 - An update to a drug in early-stage development helped catapult shares upward.
momenta pharmaceuticalsthe motleytodayfool
https://www.ftc.gov/legal-library/browse/amicus-briefs/amphastar-pharmaceuticals-inc-et-al-v-momenta-pharmaceuticals-inc-et-al
Amphastar Pharmaceuticals, Inc., et al. v. Momenta Pharmaceuticals, Inc., et al. | Federal Trade...
Nov 8, 2016 - Brief of the Federal Trade Commission as amicus curiae, taking no position on the merits of the case, but explaining that the district court erroneously...
et alamphastarpharmaceuticalsincv